UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

Prevalence and Clinical Significance of Staphylococcus aureus Small-Colony Variants in Cystic Fibrosis Lung Disease

Journal of Clinical Microbiology, 2007-01, Vol.45 (1), p.168-172

2007

Volltextzugriff (PDF)

Management of Helicobacter pylori infection in paediatric patients in Europe: results from the EuroPedHp Registry

Infection, 2023-08, Vol.51 (4), p.921-934

2023

Volltextzugriff (PDF)

Stimuli Generation for Quality-of-Experience Evaluation of Mobile Applications

International journal of interactive mobile technologies, 2022-03, Vol.16 (6), p.113-134

2022

Volltextzugriff (PDF)

Isolated Crohn's Colitis: Is Localization Crucial? Characteristics of Pediatric Patients From the CEDATA–GPGE Registry

Frontiers in pediatrics, 2022-05, Vol.10, p.875938-875938

2022

Volltextzugriff (PDF)

Inflammatory bowel disease in pediatric patients: Characteristics of newly diagnosed patients from the CEDATA-GPGE Registry

Deutsches Ärzteblatt international, 2015-02, Vol.112 (8), p.121-127

2015

Volltextzugriff (PDF)

Lipopolysaccharide binding protein, cytokine production in whole blood, and lipoproteins in cystic fibrosis

Pediatric research, 2005-11, Vol.58 (5), p.903-907

2005

Volltextzugriff (PDF)

Determination of muscle strength and function in plesiosaur limbs: finite element structural analyses of Cryptoclidus eurymerus humerus and femur

PeerJ (San Francisco, CA), 2022-06, Vol.10, p.e13342-e13342, Article e13342

2022

Volltextzugriff (PDF)

Incidence, Risk Factors, Treatment and Long Term Outcome of Refractory and First Relapse AML Patients in the OSHO Studies

Blood, 2019-11, Vol.134 (Supplement_1), p.1358-1358

2019

Volltextzugriff (PDF)

Imatinib (IM) in Combination with Hydroxyurea Showed Significantly Lower Major Molecular Response Rates at 6 Months but Similar MMR at 18 Months in Patients with CML1st CP Compared to IM Alone. Final Results of the CML2004 Study. NCT 02480608

Blood, 2017-12, Vol.130, p.1615-1615

2017

Volltextzugriff (PDF)

The effect of prior exposure to imatinib on transplant-related mortality

Haematologica (Roma), 2006-04, Vol.91 (4), p.452-459

2006

Volltextzugriff (PDF)

Comparison of Treatment Strategies in Patients over 60 Years with AML: Final Analysis of a Prospective Randomized German AML Intergroup Study

Blood, 2016-12, Vol.128 (22), p.1066-1066

2016

Volltextzugriff (PDF)

Prognostic Factors for Overall Survival in Relapsed Acute Myeloid Leukemia

Blood, 2014-12, Vol.124 (21), p.3666-3666

2014

Volltextzugriff (PDF)

Combined Bendamustine, Prednisone and Bortezomib (BPV) in Patients with Relapsed or Refractory Multiple Myeloma

Blood, 2012-11, Vol.120 (21), p.1855-1855

2012

Volltextzugriff (PDF)

Mutagenicity of diesel exhaust particles from two fossil and two plant oil fuels

Mutagenesis, 2000-09, Vol.15 (5), p.391-397

2000

Volltextzugriff (PDF)

Prognostic Factors in Adult Patients up to 60 Years with AML and Translocations of Chromosome 11q23: Individual Patient Data Based Analysis of the German AML-Intergroup

Blood, 2007-11, Vol.110 (11), p.759-759

2007

Volltextzugriff (PDF)

Prognosis of Adult Patients ≤60 Years with AML and Aberrations of Chromosome 11q23: Pooled Data Analysis of the German AML-Intergroup

Blood, 2006-11, Vol.108 (11), p.16-16

2006

Volltextzugriff (PDF)

Pooled Data Analysis of Acute Myeloid Leukemia Patients <= 60 Years with Trisomy 8 Treated within the Studies of the German Acute Myeloid Leukemia Intergroup

Blood, 2005-11, Vol.106 (11), p.2374-2374

2005

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

KollektionWiley Online Library Full Collection 2018

Zeitschrift / SerieAntioxidants

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(23)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

5 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prevalence and Clinical Significance of Staphylococcus aureus Small-Colony Variants in Cystic Fibrosis Lung Disease

Management of Helicobacter pylori infection in paediatric patients in Europe: results from the EuroPedHp Registry

Stimuli Generation for Quality-of-Experience Evaluation of Mobile Applications

Isolated Crohn's Colitis: Is Localization Crucial? Characteristics of Pediatric Patients From the CEDATA–GPGE Registry

Inflammatory bowel disease in pediatric patients: Characteristics of newly diagnosed patients from the CEDATA-GPGE Registry

Lipopolysaccharide binding protein, cytokine production in whole blood, and lipoproteins in cystic fibrosis

Determination of muscle strength and function in plesiosaur limbs: finite element structural analyses of Cryptoclidus eurymerus humerus and femur

Incidence, Risk Factors, Treatment and Long Term Outcome of Refractory and First Relapse AML Patients in the OSHO Studies

Imatinib (IM) in Combination with Hydroxyurea Showed Significantly Lower Major Molecular Response Rates at 6 Months but Similar MMR at 18 Months in Patients with CML1st CP Compared to IM Alone. Final Results of the CML2004 Study. NCT 02480608

The effect of prior exposure to imatinib on transplant-related mortality

Hematopoietic stem cell transplantation (HSCT) compared to consolidation chemotherapy (CT) to increase leukemia free survival (LFS) in acute myelogenous leukemia (AML) patients between 60 and 75 years irrespective of genetic risk: Report from the AML 2004 of the East German Study Group (OSHO)

Comparison of Treatment Strategies in Patients over 60 Years with AML: Final Analysis of a Prospective Randomized German AML Intergroup Study

Long Term Follow up of the AML97-Study for Patients with AML Older Than 60 Years: A Study of the East German Hematology and Oncology Study Group (OSHO)

Successful Stem Cell Mobilization and Autologous Stem Cell Transplantation after Pretreatment Consisting of Bendamustine, Prednisone and Bortezomib (BPV) in 35 Patients with Newly Diagnosed/Untreated Multiple Myeloma

Higher Leukemia Free Survival after Post-Induction Hematopoietic Cell Transplantation Compared to Consolidation Therapy in Patients >60 Years with Acute Myelogenous Leukemia (AML): Report from the AML 2004 East German Study Group (OSHO)

Prognostic Factors for Overall Survival in Relapsed Acute Myeloid Leukemia

Increasing The Dose Of AraC In Consolidation Therapy Does Not Lead To Higher Overall Survival Or Improved Relapse Incidence In Patients With AML Over The Age Of 60 Years

Prognostic Factors For Overall Survival In Elderly Patients With Relapsed Acute Myeloid Leukemia – Retrospective Study On Behalf Of The East German Study Group For Hematology and Oncology (OSHO)

Combined Bendamustine, Prednisone and Bortezomib (BPV) in Patients with Relapsed or Refractory Multiple Myeloma

Mutagenicity of diesel exhaust particles from two fossil and two plant oil fuels

Prognostic Factors in Adult Patients up to 60 Years with AML and Translocations of Chromosome 11q23: Individual Patient Data Based Analysis of the German AML-Intergroup

Prognosis of Adult Patients ≤60 Years with AML and Aberrations of Chromosome 11q23: Pooled Data Analysis of the German AML-Intergroup

Pooled Data Analysis of Acute Myeloid Leukemia Patients <= 60 Years with Trisomy 8 Treated within the Studies of the German Acute Myeloid Leukemia Intergroup

Aktive Filter

Suchergebnisse filtern